Previous Article | Next Article ![]()
Journal of Clinical Microbiology, May 2007, p. 1607-1610, Vol. 45, No. 5
0095-1137/07/$08.00+0 doi:10.1128/JCM.00306-07
Copyright © 2007, American Society for Microbiology. All Rights Reserved.

ska,1
Piotr Obuch-Woszczaty
ski,1
Grazyna Nurzy
ska,4
Haru Kato,5
Martin Reijans,6
Felicja Meisel-Miko
ajczyk,1
Miros
aw
uczak,1,4 and
Alex van Belkum2
Department of Medical Microbiology, Medical University of Warsaw, Warsaw, Poland,1 Department of Medical Microbiology and Infectious Diseases, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands,2 Center for Optical Diagnostics and Therapy, Department of General Surgery, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands,3 Central Public Hospital of Medical University of Warsaw, Warsaw, Poland,4 Department of Bacterial Pathogenesis and Infection Control, National Institute of Infectious Diseases, Tokyo, Japan,5 Pathofinder BV, Oxfordlaan 70, Maastrich, The Netherlands6
Received 8 February 2007/ Accepted 14 February 2007
Amplified fragment length polymorphism genotypes, antibiotic resistance profiles, and toxin profiles of Clostridium difficile strains from Warsaw were determined. The isolates segregate in six major genotypes, coinciding with toxin profiles. Most of the toxin A-negative toxin B-positive toxin CDT-negative strains possess ermB, and several strains were resistant to fluoroquinolones. Resistograms and toxin types of C. difficile strains are epidemicity determinants.
Published ahead of print on 21 February 2007.
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»